Global Brachytherapy Market, By Technique (High Dose Rate (HDR) Brachytherapy, Low Dose Rate (LDR) Brachytherapy, Pulse Dose Rate, (PDR) Brachytherapy and Image-Guided Brachytherapy (IGBT)), Application (Prostate Cancer, Breast Cancer, Gynaecological Cancer, Skin Cancer, and Others), Product (Brachytherapy After Loader, Brachytherapy Applicators and Brachytherapy Software), End-User (Hospitals, Specialty Clinics, and Others), and Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of the Middle East and Africa) Industry Trends and Forecast to 2028.
The brachytherapy market is expected to witness market growth at a rate of 7.8% in the forecast period of 2021 to 2028. Data Bridge Market Research report on the brachytherapy market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the prevalence of cancer is escalating the growth of the brachytherapy market.
Brachytherapy is known as a procedure that includes the insertion of radioactive material inside the body. This is a radiation therapy that is mainly utilized for treating cancerous cells inside the body. Occasionally it is called internal radiation.
Major factors that are expected to boost the growth of the brachytherapy market in the forecast period are the technological developments in this field. Furthermore, the research and developments investments by market players are further propelling the growth of the brachytherapy market. Moreover, the rise in the prevalence of cervical and lung cancer in advancing regions and advanced health care infrastructure is further estimated to cushion the growth brachytherapy market. On the other hand, the rise in reimbursement in the field of radiation therapy is further projected to impede the growth of the brachytherapy market in the timeline period.
In addition, the increase in the adoption of minimally invasive surgeries will further provide potential opportunities for the growth of the brachytherapy market in the coming years. However, the accessibility of alternatives in the industry might further challenge the growth of the brachytherapy market in the near future.
The brachytherapy market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the brachytherapy market scenario, contact Data bridge market research for an Analyst Brief. Our team will help you create a revenue impact solution to achieve your desired goal.
Brachytherapy Market Scope and Market Size
The brachytherapy market is segmented on the basis of technique, application, product, and end-user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of technique, the brachytherapy market is segmented into high dose rate (HDR) brachytherapy, low dose rate (LDR) brachytherapy, pulse dose rate (PDR) brachytherapy, image-guided brachytherapy (IGBT).
- On the basis of application, the brachytherapy market is segmented into prostate cancer, breast cancer, gynaecological cancer, skin cancer, others.
- On the basis of product, the brachytherapy market is segmented into brachytherapy after loader, brachytherapy applicators, and brachytherapy software.
- On the basis of end-user, the brachytherapy market is segmented into hospitals, specialty clinics, and others.
Brachytherapy Market Country Level Analysis
The brachytherapy market is analysed, and market size information is provided by country, technique, application, product, and end-user as referenced above.
The countries covered in the brachytherapy market report are the U.S., Canada, and Mexico in North America, Peru, Brazil, Argentina, and the rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, rest of Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA).
North America dominates the brachytherapy market due to the benefits it provides over traditional methods as it is a comparatively safer and efficient cancer treatment. Furthermore, the occurrence of major key players will further boost the growth of the brachytherapy market in the region during the forecast period. Asia-Pacific is projected to observe a significant amount of growth in the brachytherapy market due to the rise in the incidence of cancer is rising regarding an unhealthy lifestyle. Moreover, the limited access to technologically advanced cancer treatments is further anticipated to propel the growth of the brachytherapy market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The brachytherapy market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to the market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Brachytherapy Market Share Analysis
The brachytherapy market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to the brachytherapy market.
The major players covered in the brachytherapy market report are ECKERT & ZIEGLER BEBIG, ISORAY INC., Elekta AB (pub), Theragenics Corporation, BD, CIVCO MEDICAL SOLUTIONS, SUN NUCLEAR CORPORATION, iCAD, Inc., VARIAN MEDICAL SYSTEMS, INC., Cianna Medical, Panacea Medical Technologies Pvt. Ltd., Argon Medical., COOK, Boston Scientific Corporation, Best Vascular, Inc., CNMC Comapany Inc., MEDraysintell and Best Theratronics Ltd among other domestic and global players. The brachytherapy market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC), and the Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.